CSPC Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 6/6
CSPC Pharmaceutical Group has a total shareholder equity of CN¥33.5B and total debt of CN¥415.3M, which brings its debt-to-equity ratio to 1.2%. Its total assets and total liabilities are CN¥43.7B and CN¥10.2B respectively. CSPC Pharmaceutical Group's EBIT is CN¥6.8B making its interest coverage ratio -25.3. It has cash and short-term investments of CN¥12.8B.
Key information
1.2%
Debt to equity ratio
CN¥415.26m
Debt
| Interest coverage ratio | -25.3x |
| Cash | CN¥12.75b |
| Equity | CN¥33.51b |
| Total liabilities | CN¥10.16b |
| Total assets | CN¥43.67b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 1093 N's short term assets (CN¥24.4B) exceed its short term liabilities (CN¥9.0B).
Long Term Liabilities: 1093 N's short term assets (CN¥24.4B) exceed its long term liabilities (CN¥1.1B).
Debt to Equity History and Analysis
Debt Level: 1093 N has more cash than its total debt.
Reducing Debt: 1093 N's debt to equity ratio has reduced from 5.6% to 1.2% over the past 5 years.
Debt Coverage: 1093 N's debt is well covered by operating cash flow (1129.5%).
Interest Coverage: 1093 N earns more interest than it pays, so coverage of interest payments is not a concern.